Friday, June 07, 2024

Indian, Chinese Drugmakers Ready to Challenge Ozempic's Dominance with Palki Sharma

Very recommendable! I did not know there were so many fat people in China. So is it for export? The patent for semaglutide is about to expire in China.
I suppose, Danish company Novo Nordisk may have to lower prices soon.

No comments: